Product Details
| Product Name:
Abiraterone metabolite 1 |
CAS No.:
1940176-03-3 |
| Supply Ability:
10g |
Release date:
2025/07/21 |
Product Introduction
Bioactivity
| Name | Abiraterone metabolite 1 |
| Description | Abiraterone Metabolite 1, a 5β-reduced derivative of abiraterone, acts by inhibiting CYP17A1, thereby blocking androgen synthesis and extending survival in prostate cancer patients. |
| Storage | Powder: -20°C for 3 years | In solvent: -80°C for 1 year | Shipping with blue ice/Shipping at ambient temperature. |
| Solubility Information | DMSO : 25 mg/mL (71.12 mM), Sonication is recommended.
|
| Keywords | 3beta-OH-5alpha-Abi | Abiraterone metabolite 1 | 3b-OH-5a-Abi |
Company Profile Introduction
TargetMol Chemicals Inc. is headquartered in Boston, MA, and specializes in products and services that serve the research needs of chemical and biological scientists worldwide. With a client base in 40+ countries, TargetMol has evolved into one of the biggest global research suppliers for compound libraries and small molecule compounds.
170+ Compound Libraries， 10000+ Noval Small Molecucles，16000+ Nature Compounds
TargetMol diligently updates and offers over 170 types of compound libraries and a wide range of high-quality research chemicals, including inhibitors, activators, natural products, peptides, antibodies , and novel life-science kits for laboratory and scientific use. In addition, our lab allows us to conduct CADD (computer-aided drug design) and chemical synthesis to meet the customization needs of our clients.
You may like
-
CAS:1445846-30-9
$6339.00 / 50mg
-
CAS:1260530-25-3
$198.00 / 2mg
-
CAS:89845-16-9
$2500.00 / 100mg
Recommended supplier
| Product name |
Price |
|
Suppliers |
Update time |
|
|
$1980.00/50mg |
VIP4Y
|
TargetMol Chemicals Inc.
|
2025-07-18 |
United States